Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ICU MEDICAL INC/DEICUI · Entity 2385 | Chief Financial Officer, | February 14, 2020 | February 14, 2020 |
| Pennant Group, Inc.PNTG · Entity 4774 | Director | July 15, 2026 | July 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ICU MEDICAL INC/DE
Report date February 14, 2020 · Filed February 14, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,274 |
Ending reported balance
After 2020-02-14 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2020-02-14 · Exercise / conversion · Acquired 1,006 · Balance 16,803 Row 2 · 2020-02-14 · Tax withholding · Disposed 529 · Balance 16,274 |
| Performance SharesSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2021-02-15 | Direct | 1,005 |
Reported balance
After 2020-02-14 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-02-14 · Exercise / conversion · Disposed 1,006 · Balance 1,005 F1: These Securities are Performance-based Restricted Stock Units (PRSU). F2: There is neither a purchase price nor an exercise price for the PRSUs. F3: These PRSUs were granted on March 6, 2018. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on February 15 of the first, second, and third year following the year of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: These Securities are Performance-based Restricted Stock Units (PRSU).
F2: There is neither a purchase price nor an exercise price for the PRSUs.
F3: These PRSUs were granted on March 6, 2018. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on February 15 of the first, second, and third year following the year of grant.
Pennant Group, Inc.
Report date July 15, 2026 · Filed July 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 58,935 |
Reported balance
After 2026-07-15 transaction · row 1
1 source rowRow 1 · 2026-07-15 · Grant · Acquired 2,400 · Balance 58,935 F1: These shares vest in three annual installments beginning July 15, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares vest in three annual installments beginning July 15, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 25, 2019 Filed Jun 26, 2019 21:37 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherNon-Qualified Stock Option (right to buy) · Derivative | 21,675 | $58.79 Strike: $58.79 | $1,274,273.25 |
DisclosureSEC source: 0001375852-19-000009 · edgardoc.xml · derivative · entry 5 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,325 Underlying: Common Stock · 21,675 shares Expires 2024-02-24 F4 · price: Transaction is the exercise of a derivative security; see Column 2. F3 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the grant date . Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days. Read SEC document |
| June 25, 2019 Filed Jun 26, 2019 21:37 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 21,675 | $250.00 | $5,418,750.00 |
DisclosureSEC source: 0001375852-19-000009 · edgardoc.xml · nonDerivative · entry 2 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,309 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 11, 2019. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| June 25, 2019 Filed Jun 26, 2019 21:37 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherCommon Stock | 21,675 | $58.79 | $1,274,273.25 |
DisclosureSEC source: 0001375852-19-000009 · edgardoc.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,984 Read SEC document |
| March 27, 2019 Filed Mar 28, 2019 18:08 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 593 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001375852-19-000008 · edgardoc.xml · derivative · entry 3 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 593 Underlying: Common Stock · 593 shares Expires 2020-03-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| March 27, 2019 Filed Mar 28, 2019 18:08 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 593 | $0.00 | $0.00 |
DisclosureSEC source: 0001375852-19-000008 · edgardoc.xml · nonDerivative · entry 2 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,309 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 27, 2019 Filed Mar 28, 2019 18:08 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 295 | $0.00 | $0.00 |
DisclosureSEC source: 0001375852-19-000008 · edgardoc.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,716 Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 18:09 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 2,742 | $0.00 | $0.00 |
DisclosureSEC source: 0001375852-19-000006 · edgardoc.xml · derivative · entry 3 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,226 shares Expires 2019-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F3 · shares: Each PRSU reflects the contingent right to receive a variable number of shares of common stock based on achieving performance goals. At the determination date, based on certification of the achievement of the performance criteria, the reporting person earned 300% of the target award amount. F4 · derivative.exercise_date: These PRSUs were granted on February 5, 2016. The vesting for these PRSUs is dependent upon the achievement of performance criteria related to the Company's fiscal year 2018 Adjusted EBITDA per share CAGR in comparison to the fiscal year 2015 Adjusted EBITDA per weighted average basic share. The reporting person may potentially earn 100% to 300% of the target award amount originally reported on the date of grant. Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 18:09 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 4,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001375852-19-000006 · edgardoc.xml · nonDerivative · entry 2 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,011 Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 18:09 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 8,226 | $0.00 | $0.00 |
DisclosureSEC source: 0001375852-19-000006 · edgardoc.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,064 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2019 Filed Feb 22, 2019 17:26 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 1,006 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001375852-19-000004 · edgardoc.xml · derivative · entry 3 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,011 Underlying: Common Stock · 1,006 shares Expires 2021-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the performance stock units. F3 · derivative.exercise_date: These performance stock units were granted on March 6, 2018. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These performance stock units vest on February 15 of the first, second, and third year following the year of grant. Read SEC document |
| February 15, 2019 Filed Feb 22, 2019 17:26 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 348 | $0.00 | $0.00 |
DisclosureSEC source: 0001375852-19-000004 · edgardoc.xml · nonDerivative · entry 2 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,838 Read SEC document |
| February 15, 2019 Filed Feb 22, 2019 17:26 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,006 | $0.00 | $0.00 |
DisclosureSEC source: 0001375852-19-000004 · edgardoc.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,186 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2019 Filed Feb 6, 2019 00:24 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 914 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001375852-19-000002 · edgardoc.xml · derivative · entry 3 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 914 shares Expires 2019-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| February 05, 2019 Filed Feb 6, 2019 00:24 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 914 | $0.00 | $0.00 |
DisclosureSEC source: 0001375852-19-000002 · edgardoc.xml · nonDerivative · entry 2 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,180 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2019 Filed Feb 6, 2019 00:24 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 339 | $0.00 | $0.00 |
DisclosureSEC source: 0001375852-19-000002 · edgardoc.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,266 Read SEC document |
| March 27, 2018 Filed Mar 28, 2018 22:28 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 592 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001375852-18-000008 · edgardoc.xml · derivative · entry 3 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,186 Underlying: Common Stock · 592 shares Expires 2020-03-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| March 27, 2018 Filed Mar 28, 2018 22:28 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 294 | $0.00 | $0.00 |
DisclosureSEC source: 0001375852-18-000008 · edgardoc.xml · nonDerivative · entry 2 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,605 Read SEC document |
| March 27, 2018 Filed Mar 28, 2018 22:28 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 592 | $0.00 | $0.00 |
DisclosureSEC source: 0001375852-18-000008 · edgardoc.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,899 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| February 11, 2018 Filed Feb 13, 2018 21:28 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 1,484 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001375852-18-000006 · edgardoc.xml · derivative · entry 3 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,484 shares Expires 2018-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| February 11, 2018 Filed Feb 13, 2018 21:28 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 736 | $0.00 | $0.00 |
DisclosureSEC source: 0001375852-18-000006 · edgardoc.xml · nonDerivative · entry 2 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,307 Read SEC document |
| February 11, 2018 Filed Feb 13, 2018 21:28 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,484 | $0.00 | $0.00 |
DisclosureSEC source: 0001375852-18-000006 · edgardoc.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,043 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 01:19 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 914 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001375852-18-000004 · edgardoc.xml · derivative · entry 3 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 914 Underlying: Common Stock · 914 shares Expires 2019-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 01:19 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 454 | $0.00 | $0.00 |
DisclosureSEC source: 0001375852-18-000004 · edgardoc.xml · nonDerivative · entry 2 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,559 Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 01:19 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 914 | $0.00 | $0.00 |
DisclosureSEC source: 0001375852-18-000004 · edgardoc.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,013 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| January 04, 2018 Filed Jan 5, 2018 00:49 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherNon-Qualified Stock Option (right to buy) · Derivative | 23,624 | $61.76 Strike: $61.76 | $1,459,018.24 |
DisclosureSEC source: 0001375852-18-000002 · edgardoc.xml · derivative · entry 3 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 23,624 shares Expires 2023-02-06 F4 · price: Transaction is the exercise of a derivative security; see Column 2. F3 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
| January 04, 2018 Filed Jan 5, 2018 00:49 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 23,624 | $220.00 | $5,197,280.00 |
DisclosureSEC source: 0001375852-18-000002 · edgardoc.xml · nonDerivative · entry 2 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,099 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 28, 2017. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| January 04, 2018 Filed Jan 5, 2018 00:49 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherCommon Stock | 23,624 | $61.76 | $1,459,018.24 |
DisclosureSEC source: 0001375852-18-000002 · edgardoc.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,723 Read SEC document |
| July 11, 2017 Filed Jul 12, 2017 00:12 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherNon-Qualified Stock Option (right to buy) · Derivative | 20,774 | $46.53 Strike: $46.53 | $966,614.22 |
DisclosureSEC source: 0001375852-17-000004 · edgardoc.xml · derivative · entry 7 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 0 shares Expires 2022-02-01 F4 · price: Transaction is the exercise of a derivative security; see Column 2. F3 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
| July 11, 2017 Filed Jul 12, 2017 00:12 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 20,774 | $170.00 | $3,531,580.00 |
DisclosureSEC source: 0001375852-17-000004 · edgardoc.xml · nonDerivative · entry 5 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,052 F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| July 11, 2017 Filed Jul 12, 2017 00:12 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherCommon Stock | 20,774 | $46.53 | $966,614.22 |
DisclosureSEC source: 0001375852-17-000004 · edgardoc.xml · nonDerivative · entry 4 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,826 Read SEC document |
| July 10, 2017 Filed Jul 12, 2017 00:12 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherNon-Qualified Stock Option (right to buy) · Derivative | 2,998 | $46.53 Strike: $46.53 | $139,496.94 |
DisclosureSEC source: 0001375852-17-000004 · edgardoc.xml · derivative · entry 6 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,774 Underlying: Common Stock · 0 shares Expires 2022-02-01 F4 · price: Transaction is the exercise of a derivative security; see Column 2. F3 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
| July 10, 2017 Filed Jul 12, 2017 00:12 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 300 | $171.00 | $51,300.00 |
DisclosureSEC source: 0001375852-17-000004 · edgardoc.xml · nonDerivative · entry 3 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,052 F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| July 10, 2017 Filed Jul 12, 2017 00:12 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 2,698 | $170.04 | $458,755.78 |
DisclosureSEC source: 0001375852-17-000004 · edgardoc.xml · nonDerivative · entry 2 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,352 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $170.00 to $170.80, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| July 10, 2017 Filed Jul 12, 2017 00:12 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherCommon Stock | 2,998 | $46.53 | $139,496.94 |
DisclosureSEC source: 0001375852-17-000004 · edgardoc.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,050 Read SEC document |
| March 27, 2017 Filed Apr 4, 2017 01:02 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantCommon Stock · Derivative | 1,778 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001375852-17-000003 · edgardoc.xml · derivative · entry 2 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,778 Underlying: Common Stock · 1,778 shares Expires 2020-03-27 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · date: The executive officers were notified of their awards by the Registrant on March 30, 2017. F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F5 · derivative.exercise_date: One third of the Units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| March 27, 2017 Filed Apr 4, 2017 01:02 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | GrantCommon Stock · Derivative | 1,778 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001375852-17-000003 · edgardoc.xml · derivative · entry 1 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,778 Underlying: Common Stock · 1,778 shares Expires 2019-12-31 F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · date: The executive officers were notified of their awards by the Registrant on March 30, 2017. F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: The vesting for this performance-based restricted stock unit ("PRSU") award is dependent upon the reporting person's earning PRSUs based on the achievement of performance criteria related to the Company's fiscal year 2019 Cumulative Adjusted EBITDA in comparison to the fiscal year 2016 Adjusted EBITDA. The number of shares reported is the target award amount. The reporting person may potentially earn PRSUs ranging from 100% to 300% of the target award amount. Read SEC document |
| February 11, 2017 Filed Feb 13, 2017 17:09 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 1,484 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001375852-17-000002 · edgardoc.xml · derivative · entry 3 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,484 Underlying: Common Stock · 1,484 shares Expires 2018-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the Units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| February 11, 2017 Filed Feb 13, 2017 17:09 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 557 | $145.70 | $81,154.90 |
DisclosureSEC source: 0001375852-17-000002 · edgardoc.xml · nonDerivative · entry 2 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,839 Read SEC document |
| February 11, 2017 Filed Feb 13, 2017 17:09 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,484 | $0.00 | $0.00 |
DisclosureSEC source: 0001375852-17-000002 · edgardoc.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,396 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| February 05, 2017 Filed Feb 6, 2017 17:21 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 914 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001375852-17-000001 · edgardoc.xml · derivative · entry 3 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,828 Underlying: Common Stock · 914 shares Expires 2019-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the Units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. Read SEC document |
| February 05, 2017 Filed Feb 6, 2017 17:21 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 383 | $0.00 | $0.00 |
DisclosureSEC source: 0001375852-17-000001 · edgardoc.xml · nonDerivative · entry 2 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,912 Read SEC document |
| February 05, 2017 Filed Feb 6, 2017 17:21 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 914 | $0.00 | $0.00 |
DisclosureSEC source: 0001375852-17-000001 · edgardoc.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,295 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| September 13, 2016 Filed Sep 13, 2016 23:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherNon-Qualified Stock Option (right to buy) · Derivative | 324 | $43.62 Strike: $43.62 | $14,132.88 |
DisclosureSEC source: 0001375852-16-000009 · edgardoc.xml · derivative · entry 7 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 324 shares Expires 2021-07-20 F6 · price: Transaction is the exercise of a derivative security; see Column 2. F5 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
| September 13, 2016 Filed Sep 13, 2016 23:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherNon-Qualified Stock Option (right to buy) · Derivative | 1,150 | $43.12 Strike: $43.12 | $49,588.00 |
DisclosureSEC source: 0001375852-16-000009 · edgardoc.xml · derivative · entry 6 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,150 shares Expires 2021-02-02 F6 · price: Transaction is the exercise of a derivative security; see Column 2. F5 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
| September 13, 2016 Filed Sep 13, 2016 23:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 700 | $121.93 | $85,353.03 |
DisclosureSEC source: 0001375852-16-000009 · edgardoc.xml · nonDerivative · entry 5 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,381 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.91 to $121.99, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 13, 2016 Filed Sep 13, 2016 23:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 450 | $120.82 | $54,370.49 |
DisclosureSEC source: 0001375852-16-000009 · edgardoc.xml · nonDerivative · entry 4 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,081 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.80 to $120.83, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 13, 2016 Filed Sep 13, 2016 23:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherCommon Stock | 1,150 | $43.12 | $49,588.00 |
DisclosureSEC source: 0001375852-16-000009 · edgardoc.xml · nonDerivative · entry 3 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,531 Read SEC document |
| September 13, 2016 Filed Sep 13, 2016 23:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 324 | $122.01 | $39,531.01 |
DisclosureSEC source: 0001375852-16-000009 · edgardoc.xml · nonDerivative · entry 2 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,381 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.75 to $122.13, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 13, 2016 Filed Sep 13, 2016 23:22 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherCommon Stock | 324 | $43.62 | $14,132.88 |
DisclosureSEC source: 0001375852-16-000009 · edgardoc.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,705 Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 19:29 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherNon-Qualified Stock Option (right to buy) · Derivative | 14,676 | $43.62 Strike: $43.62 | $640,167.12 |
DisclosureSEC source: 0001375852-16-000008 · edgardoc.xml · derivative · entry 8 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324 Underlying: Common Stock · 14,676 shares Expires 2021-07-20 F7 · price: Transaction is the exercise of a derivative security; see Column 2. F6 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.